Numinus Bioscience News Today

Q4 Fiscal 2023 Highlights Q4 2023 revenues grew 46.8% year-over-year to $6.1 million Q4 2023 revenues grew 1.7% from the previous quarter Gross profit of $1.8...

Q4 Fiscal 2023 Highlights Q4 2023 revenues grew 46.8% year-over-year to $6.1 millionQ4 2023 revenues grew 1.7% from the previous quarterGross profit of $1.8 million, increased 37.4%...

Drugs demonised by their recreational use in the 1960s are proving their worth in helping to improve people’s mental health. Soon they will be coming to a doctor’s practice near you.

Gov. Gavin Newsom has vetoed a bill aimed at decriminalizing the possession and personal use of several hallucinogens, including psychedelic mushrooms.

MARKET WRAPS Watch For: Housing Starts for August; Canada Consumer Price Index for August; Instacart IPO Todays Top Headlines/Must Reads: - American Business Confidence in China... -September 19, 2023 at 06:11 am EDT - MarketScreener

By Ben Glickman Numinus Wellness will shut down its research lab and consolidate wellness clinics in a reorganization focused on its cash-flow generating...

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

Numinus Wellness (OTCMKTS:NUMIF – Get Rating) and ATI Physical Therapy (NYSE:ATIP – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, profitability, institutional ownership, dividends and risk. Analyst Recommendations This is a summary of current recommendations […]

NUMI | Complete Numinus Wellness Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Magic mushrooms, and other psychedelics, are suddenly everywhere — in clinical trials and being touted as a cure for treatment-resistant depression